Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTP-543 effect on oral contraceptives PK
NCT04309643Phase 1Completed
- Sponsor
- Concert Pharmaceuticals
- Start
- Jun 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of deuruxolitinib in alopecia areata, sponsored by Concert Pharmaceuticals. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to Time t at 16 days, Area Under the Concentration-Time Curve From Time Zero to Infinity at 16 days and 1 more. Started Jun 2020; status: completed.
02
Drugs
deuruxolitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04309643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04309643.